Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)

NCT00006164 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00006164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial (HALT-C)
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2000
Completion date
October 31, 2009
Enrollment
1,050 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, cirrhosis, liver, fibrosis, liver, hepatic cirrhosis